Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Neurogastroenterol Motil. 2021 Jan 11;33(8):e14081. doi: 10.1111/nmo.14081

Table 2.

Comparisons in Demographic, Clinical, and Psychological Variables between AET and SI groups

AET Sample SI Sample

0 Days (N = 49) 1-2 Days (N = 44) 3+ Days (N = 30) P-Value 0 Days (N = 72) 1 Day (N = 23) 2+ Days (N = 21) P-Value
Age 47.53 52.73 50.00 .267 49.92 52.96 47.33 .482
GerdQ 8.71 9.43 10.40 .038 8.76 9.78 10.90 <.01
Total Symptoms 5.00 8.00 6.00 .035 4.00 7.00 12.00 <.01
EHAS Total 29.35 33.68 31.33 .311 29.08 35.30 33.38 .118
 Hypervigilance 11.67 12.66 12.13 .709 11.51 12.87 13.24 .365
 Anxiety 17.67 21.02 18.97 .183 17.57 22.43 20.14 .057

Self-reported symptom frequency presented as median scores and analyzed using Kruskal Wallace Test

P < .05 compared to 0 Day positive AET/SI group